Diagnosis of extracavitary primary effusion lymphoma by urine cytologyBlood. 2012, Vol 119, Num 12, issn 0006-4971, p. 2707Article

Curcumin suppresses growth and induces apoptosis in primary effusion lymphomaUDDIN, Shahab; HUSSAIN, Azhar R; MANOGARAN, Pulicat S et al.Oncogene (Basingstoke). 2005, Vol 24, Num 47, pp 7022-7030, issn 0950-9232, 9 p.Article

Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma CellsXUDONG LI; JIAYING FENG; REN SUN et al.Journal of virology. 2011, Vol 85, Num 2, pp 715-724, issn 0022-538X, 10 p.Article

Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral associationWEN FAN; BUBMAN, Darya; CHADBURN, Amy et al.Journal of virology. 2005, Vol 79, Num 2, pp 1244-1251, issn 0022-538X, 8 p.Article

Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapyCRUM-CIANFLONE, Nancy F; WALLACE, Mark R; LOONEY, David et al.AIDS (London). 2006, Vol 20, Num 11, pp 1567-1569, issn 0269-9370, 3 p.Article

Primary effusion lymphoma in a HIV-negative patient associated with hypogammaglobulinemiaGANZEL, Chezi; ROWE, Jacob M; RUCHLEMER, Rosa et al.American journal of hematology. 2011, Vol 86, Num 9, pp 777-781, issn 0361-8609, 5 p.Article

Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphomaMATE, José-Luis; NAVARRO, José-Tomas; GRANADA, Isabel et al.Human pathology. 2004, Vol 35, Num 5, pp 632-635, issn 0046-8177, 4 p.Article

Primary effusion lymphoma: A case reportIOAKIM-LIOSSI, Anna; MIKOU, Panagiota; BOTSOLI-STERGIOU, Efi et al.Acta cytologica. 2004, Vol 48, Num 2, pp 269-272, issn 0001-5547, 4 p.Article

An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8SHIMAZAKI, Masaru; FUJITA, Miri; KIKUIRI, Tsuyoshi et al.European journal of haematology. 2003, Vol 71, Num 1, pp 62-67, issn 0902-4441, 6 p.Article

Primary Effusion Lymphoma in Two HIV-Negative Patients Successfully Treated with Pleurodesis as First-line TherapyIAKOUMIS, X; PANGALIS, G. A; SACHANAS, S et al.Anticancer research. 2010, Vol 30, Num 1, pp 271-276, issn 0250-7005, 6 p.Article

Remission After Radiotherapy for a Patient With Chemotherapy-Refractory HIV-Associated Primary Effusion LymphomaCASSONI, Anna; ALI, Usman; CAVE, Judith et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5297-5299, issn 0732-183X, 3 p.Article

Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphomaCHIBA, H; MATSUNAGA, T; KURIBAYASHI, K et al.Annals of hematology (Print). 2003, Vol 82, Num 12, pp 773-776, issn 0939-5555, 4 p.Article

X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein―Barr virus in co-infected primary effusion lymphomaLAI, Imogen Yi-Chun; FARRELL, Paul J; KELLAM, Paul et al.Journal of general virology. 2011, Vol 92, pp 421-431, issn 0022-1317, 11 p., 2Article

Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Necessary for Lytic Viral Gene Expression, DNA Replication, and Virion Production in Primary Effusion Lymphoma Cell LinesLEFORT, Sylvain; FLAMAND, Louis.Journal of virology. 2009, Vol 83, Num 11, pp 5869-5880, issn 0022-538X, 12 p.Article

Infection of HHV-8⁺ primary effusion lymphoma cells with a recombinant epstein-barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expressionTRIVEDI, Pankaj; TAKAZAWA, Kumi; FAGGIONI, Alberto et al.Blood. 2004, Vol 103, Num 1, pp 313-316, issn 0006-4971, 4 p.Article

The use of antiviral drugs in the prevention and treatment of kaposi sarcoma, multicentric castleman disease and primary effusion lymphomaCASPER, C; WALD, A.Current Topics in Microbiology and Immunology. 2007, Vol 312, pp 289-307, issn 0070-217X, 19 p.Article

Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cellsZAHIDUNNABI DEWAN, Md; TERUNUMA, Hiroshi; YAMAMOTO, Naoki et al.Cancer science. 2006, Vol 97, Num 12, pp 1381-1387, issn 1347-9032, 7 p.Article

Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution studySIMONELLI, Cecilia; SPINA, Michele; CINELLI, Roberta et al.Journal of clinical oncology. 2003, Vol 21, Num 21, pp 3948-3954, issn 0732-183X, 7 p.Article

A case of HHV-8-associated HIV-negative primary effusion lymphoma in MoscowSHIROKOV, D; KADYROVA, E; ANOKHINA, M et al.Journal of medical virology. 2007, Vol 79, Num 3, pp 270-277, issn 0146-6615, 8 p.Article

Prognostic factors and outcome of human herpesvirus 8 -associated primary effusion lymphoma in patients with AIDSBOULANGER, Emmanuelle; GERARD, Laurence; GABARRE, Jean et al.Journal of clinical oncology. 2005, Vol 23, Num 19, pp 4372-4380, issn 0732-183X, 9 p.Article

9-(2-C-Cyano-2-deoxy-β-D)-arabino-pentofuranosylguanine, a potential antitumor agent against B-lymphoma infected with kaposi's sarcoma-associated herpesvirusOHTAWA, Masaki; ICHIKAWA, Satoshi; TEISHIKATA, Yasuhiro et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 9, pp 2007-2010, issn 0022-2623, 4 p.Article

KSHV viral cyclin inactivates p27^KIP1 through SerlO and Thr187 phosphorylation in proliferating primary effusion lymphomasSAREK, Grzegorz; JÄRVILUOMA, Annika; OJALA, Päivi M et al.Blood. 2006, Vol 107, Num 2, pp 725-732, issn 0006-4971, 8 p.Article

Herpèsvirus humain 8 : bases moléculaires de l'oncogenèse et de la modulation de la réponse immunitaire = Human herpes virus 8 : molecules determinants of oncogenesis and modulation of the immune responseBOULANGER, E; GESSAIN, A.Virologie (Montrouge). 2006, Vol 10, Num 5, pp 369-382, issn 1267-8694, 14 p.Article

Inhibition of Phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cellsUDDIN, Shahab; HUSSAIN, Azhar R; AL-HUSSEIN, Khaled A et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 3102-3108, issn 1078-0432, 7 p.Article

The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cellsWIES, Effi; MORI, Yasuko; HAHN, Alexander et al.Blood. 2008, Vol 111, Num 1, pp 320-327, issn 0006-4971, 8 p.Article